HealthFlex
×
  • About Us
    • Management
    • Family of Companies
    • History
    • Facilities
    • Humane Care Commitment
    •  Board of Directors
  • Services
    • Toxicology
    • Bioanalytical / Analytical Chemistry
    • Pharmacokinetics / Toxicokinetics
    • Formulation
    • Pharmacology
    • Agrochemicals and Commodity Chemicals
    • Medicinal Chemistry
    • Colony Maintenance
    • Ocular
  • Specialty Expertise
    • Respiratory
    • Infectious Disease
    • Gene Therapy
    • Neuroscience
    • Alternative Tobacco Products
    • Medical Countermeasures
  • COVID-19 Research
  • News
    • Publications
    • Blog
  • Careers
    • Benefits & Compensation
  • Contact
  • For Employees
Lovelace Biomedical Operations During the Coronavirus Pandemic
Andrew L. Salzman, M.D.

Andrew L. Salzman, M.D.

Director of Translational Science (Drug Development/Medicine)

Andrew L. Salzman, M.D., is Director of Translational Science. In addition to 175 journal articles, Dr. Salzman holds numerous patents in the fields of medicine, pharmacology, organic chemistry and medical devices. As a pharmaceutical entrepreneur, Dr. Salzman founded and built Inotek Pharmaceuticals, raised $80 million in venture capital and concluded a $600 million license with Genentech based on a pharmacological inhibitor he invented. Dr. Salzman received his undergraduate degree from at Yale University, followed by a medical degree from Harvard Medical School and fellowships in pediatric critical care, neonatology and infectious disease at the Weizmann Institute of Science, Boston Children’s Hospital, Massachusetts General Hospital, University of Massachusetts and Beth Israel Hospital.

For General needs and employment verification

(505) 348-9361

info@lrri.org

www.lovelacebiomedical.org

2425 Ridgecrest Dr. SE, Albuquerque, NM 87108-5127

For Business Development Needs

For Business Development Needs

(202) 819-5108

mmcmullen@lovelacebiomedical.org

www.lovelacebiomedical.org

2425 Ridgecrest Dr. SE, Albuquerque, NM 87108-5127

Quick Links

  • Home
  • About Us
  • History
  • Humane Care Commitment
  • Services
  • Specialty Expertise
  • News
  • Careers
  • COVID-19 Research
  • Contact

Latest News

  • Blog: Preclinical Drug Development for a Gene Therapy Product: No Cookie Cutter Route Jan 11

    Preclinical Drug Development for a Gene Therapy Product: No Cookie Cutter Route   Follow these critical steps...

  • Blog Post – 2020: The Year of the Scientist Dec 14

      was the year of the scientist. In a culture where we primarily celebrate the accomplishments of...

Copyright © 2018 Lovelace Biomedical. All Rights Reserved.
Powered by J B Soft System, Chennai.